Back to results
US 2013/0261072 A1Published application
Oligomer conjugates of heteropentacyclic nucleosides
AssigneeNektar Therapeutics
InventorsBo-Liang Deng, Timothy A. Riley, Jennifer Riggs-Sauthier
Life of this patent
Estimating the term…
Abstract
The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer
Claims20
-24. (canceled)
A method comprising administering to a subject a compound having the following structure:
- wherein:
- R2 is hydrogen or hydroxyl;
- R3 is hydroxyl when R2 is hydrogen and R3 is hydrogen when R2 is hydroxyl;
- (a) is two;
- X is an amide linkage;
- and
- each POLY is independently a water-soluble, non-peptidic oligomer, and 5’-phosphates and 3′,5′-cyclic phosphates thereof and ammonium and alkali metal salts of each of the 5′-phosphates and 3′,5′-cyclic phosphates.
4 more elements
Dependencies are inferred from the claim text.